Oculis intends to use the net proceeds from the Offering to advance and accelerate its clinical development pipeline, particularly the development of its novel neuroprotective clinical candidate ...

But I think it is worth trying that new version. Especially, when there contains mino changes (usually in enhancement), we will release the rc version before a standard release. So, if you upgrade ...